J&J Acquires Heart Failure Implant Company V-Wave For Up To $1.7Bn, Expanding Its Medtech Portfolio In Cardiology

 
• By Marion Webb

J&J buys heart failure implant company V-Wave, whose Ventura Interatrial Shunt could be the first device of its kind aimed to reach the roughly 800,000 patients in the US who experience heart failure and reduce ejection fraction every year.

I-Wave's Ventura shunt
• Source: Johnson & Johnson

More from Deals

More from Business